Prediction models for postoperative recurrence in papillary thyroid carcinoma: a systematic review and critical appraisal - Report - MDSpire

Prediction models for postoperative recurrence in papillary thyroid carcinoma: a systematic review and critical appraisal

  • By

  • Yunqi Yang

  • Pengcheng Wang

  • Lin Zhou

  • Ruigang Diao

  • Chenyu Guo

  • July 15, 2026

Share

Clinical Report: Systematic Review and Critical Evaluation of Prediction Models for Postoperative Recurrence in Papillary Thyroid Carcinoma

Overview

This systematic review evaluates multivariable prediction models for structural postoperative recurrence in papillary thyroid carcinoma (PTC). The findings indicate limitations due to high risk of bias and methodological weaknesses.

Background

Thyroid cancer, particularly papillary thyroid carcinoma (PTC), is the most common endocrine malignancy, with a rising incidence. Postoperative recurrence poses challenges to patient management and long-term survival. Accurate prediction models are important for identifying high-risk patients and optimizing follow-up strategies.

Data Highlights

Thirteen retrospective studies were included, all from East Asian populations. Most studies reported AUC or C-index values exceeding 0.70. However, all studies had a high overall risk of bias, primarily due to limitations in analysis and validation methods.

Key Findings

  • Thirteen studies focused on structural postoperative recurrence in PTC were reviewed.
  • Most studies reported AUC or C-index values >0.70.
  • All studies exhibited a high overall risk of bias, particularly in analysis and validation.
  • Only two studies performed external validation of their models.
  • Exploratory pooling of validation AUCs indicated substantial heterogeneity.

Clinical Implications

The findings indicate a need for improved methodological rigor in developing prediction models for PTC recurrence.

Conclusion

Current prediction models for structural recurrence in PTC are limited by methodological weaknesses and a lack of external validation.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer - Stephanie Smooke Praw, Benjamin J. Gigliotti, Alex Tessnow, Hyunseok Kang, Debra J. Margulies, 2025
  6. International Consensus on the Requirements for Definitions of Complete Remission and Recurrence of Differentiated Thyroid Cancer: a Delphi Study (ICON-DTC) | European Journal of Endocrinology | Oxford Academic
  7. Recurrence risk of differentiated thyroid cancer treated with total or hemithyroidectomy: systematic review and meta-analysis - PMC
  8. Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer - Stephanie Smooke Praw, Benjamin J. Gigliotti, Alex Tessnow, Hyunseok Kang, Debra J. Margulies, 2025
  9. International Consensus on the Requirements for Definitions of Complete Remission and Recurrence of Differentiated Thyroid Cancer: a Delphi Study (ICON-DTC) | European Journal of Endocrinology | Oxford Academic
  10. Recurrence risk of differentiated thyroid cancer treated with total or hemithyroidectomy: systematic review and meta-analysis - PMC

Original Source(s)

Related Content